» Articles » PMID: 6632919

Propranolol Binding in Serum: Comparison of Methods and Investigation of Effects of Drug Concentration, PH, and Temperature

Overview
Specialties Pharmacology
Toxicology
Date 1983 Aug 1
PMID 6632919
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Three methods, equilibrium dialysis, ultrafiltration through dialysis bags, and ultrafiltration through ultrafree filters were compared for the determination of propranolol binding in serum. The method of choice was equilibrium dialysis, which gave values for the free fraction which were not significantly different from those obtained by ultrafiltration through the filters. Of the three methods, equilibrium dialysis also had the best precision and required the least sample volume (1 ml). Similar values for the free fraction were also obtained using either 14C- or 3H-radiolabeled propranolol by this method. Investigation of the effect of temperature and pH of serum indicated that small changes in either parameter could result in up to twofold alterations in the free fraction, but changes in propranolol concentrations over the range 10-500 ng/ml had little effect on the free fraction. Using a standardized equilibrium dialysis method (i.e., 4 hr dialysis against isotonic phosphate buffer, at 37 degrees C, pH 7.4), a mean free fraction of 14.7% (range 8.4-23.3) was observed in 34 samples from 21 healthy subjects. This was significantly greater (p less than 0.001) than that (6.8%, range 3.1-12.3) found in nine elderly hospitalized patients with acute disease. The patients also had significantly raised levels of alpha 1-acid glycoprotein (AAG), which is a major binding protein for propranolol in serum. A significant linear correlation (r = 0.884, p less than 0.02) was found between the binding ratio for propranolol and serum AAG concentrations in these subjects.

Citing Articles

The effects of aerobic exercise and heat stress on the unbound fraction of caffeine.

McLaughlin M, Dizon K, Jacobs I Front Physiol. 2025; 15():1370586.

PMID: 39835198 PMC: 11744008. DOI: 10.3389/fphys.2024.1370586.


The clinical relevance of plasma protein binding changes.

Roberts J, Pea F, Lipman J Clin Pharmacokinet. 2012; 52(1):1-8.

PMID: 23150213 DOI: 10.1007/s40262-012-0018-5.


PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.

Levitt D BMC Clin Pharmacol. 2002; 2:5.

PMID: 12182760 PMC: 126244. DOI: 10.1186/1472-6904-2-5.


Alpha 1-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness.

Paxton J, Briant R Br J Clin Pharmacol. 1984; 18(5):806-10.

PMID: 6508990 PMC: 1463558. DOI: 10.1111/j.1365-2125.1984.tb02548.x.


The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.

Hill M, Abramson F Clin Pharmacokinet. 1988; 14(3):156-70.

PMID: 3286084 DOI: 10.2165/00003088-198814030-00004.